Realta Investment Advisors’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Realta Investment Advisors’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-123	Closed	-$5.3K	–	830
2024 Q1	$5.3K	Buy	+123	New	+$5.3K	﹤0.01%	739
2023 Q4	–	Sell	-123	Closed	-$5.04K	–	812
2023 Q3	$5.04K	Sell	123 -100	-45%	-$4.23K	﹤0.01%	718
2023 Q2	$9.14K	Buy	+223	New	+$9.21K	﹤0.01%	732
2023 Q1	–	Sell	-223	Closed	-$9.13K	–	843
2022 Q4	$9.13K	Hold	223	–	–	﹤0.01%	723
2022 Q3	$9K	Buy	+223	New	+$9.54K	﹤0.01%	711
2020 Q1	–	Sell	-608	Closed	-$25K	–	1434
2019 Q4	$25K	Sell	608 -100	-14%	-$3.96K	0.01%	856
2019 Q3	$26K	Hold	708	–	–	0.01%	847
2019 Q2	$28K	Hold	708	–	–	0.01%	827
2019 Q1	$29K	Buy	+708	New	+$28.8K	0.01%	678

Other funds holding XPH

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Equitable Holdings New York $16.7B AUM 24.23% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.28% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Realta Investment Advisors's XPH Position: Q2 2024 in Review

Realta Investment Advisors sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2024, closing a stake of 123 shares — an estimated $5.3K sold.

Realta Investment Advisors first reported a position in XPH in Q1 2019 and held it in 9 quarters. The position peaked at $29K in Q1 2019. 71 funds tracked by Wall St. Rank hold XPH as of Q2 2024.

Realta Investment Advisors reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2024 after selling out during the quarter.
Realta Investment Advisors sold 123 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2024, an estimated $5.3K.
Realta Investment Advisors first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2019 and held it in 9 quarters.
Realta Investment Advisors's State Street SPDR S&P Pharmaceuticals ETF position peaked at $29K in Q1 2019.
71 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2024.

Based on Realta Investment Advisors's 13F filing for Q2 2024, filed 15 Jul 2024.